TIAA Trust, National Association
CHRS icon

TIAA Trust, National Association’s Coherus Oncology CHRS Stock Holding History

TIAA Trust, National Association’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,261
Closed -$47.2K – 647
2024
Q2 		$47.2K Buy
+27,261
New +$54.9K ﹤0.01% 628

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIAA Trust, National Association's CHRS Position: Q3 2024 in Review

TIAA Trust, National Association sold out of Coherus Oncology (CHRS) in Q3 2024, closing a stake of 27,261 shares — an estimated $47.2K sold.

TIAA Trust, National Association first reported a position in CHRS in Q2 2024 and held it in 1 quarter. The position peaked at $47.2K in Q2 2024. 128 funds tracked by Wall St. Rank hold CHRS as of Q3 2024.

  • TIAA Trust, National Association reported no remaining Coherus Oncology position as of Q3 2024 after selling out during the quarter.
  • TIAA Trust, National Association sold 27,261 Coherus Oncology shares in Q3 2024, an estimated $47.2K.
  • TIAA Trust, National Association first reported a position in Coherus Oncology in Q2 2024 and held it in 1 quarter.
  • TIAA Trust, National Association's Coherus Oncology position peaked at $47.2K in Q2 2024.
  • 128 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2024.

Based on TIAA Trust, National Association's 13F filing for Q3 2024, filed 13 Nov 2024.